{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:04:40Z","timestamp":1789736680904,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2014\/50928-2"],"award-info":[{"award-number":["2014\/50928-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["313432\/2023-6"],"award-info":[{"award-number":["313432\/2023-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["407585\/2021-4"],"award-info":[{"award-number":["407585\/2021-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["465687\/2014-8"],"award-info":[{"award-number":["465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","award":["21\/2551-0002065-2"],"award-info":[{"award-number":["21\/2551-0002065-2"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nano.2024.102779","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T06:57:48Z","timestamp":1723618668000},"page":"102779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy and safety of a 0.05\u00a0% nanoencapsulated imiquimod hydrogel for the treatment of actinic cheilitis: Drug release analysis and clinical study"],"prefix":"10.1016","volume":"62","author":[{"given":"Eduardo Liberato","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick Souza","family":"Pedra\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Pias","family":"Salgueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Pletsch","family":"Gazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Silveira","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Cavagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Ant\u00f4nio Trevizani","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis Varvaki","family":"Rados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Raffin","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Stanis\u00e7uaski","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Abrah\u00e3o","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Visioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nano.2024.102779_bb0005","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/odi.13704","article-title":"Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer","volume":"27","author":"Warnakulasuriya","year":"2021","journal-title":"Oral Dis"},{"key":"10.1016\/j.nano.2024.102779_bb0010","article-title":"Malignant transformation of actinic cheilitis: a systematic review of observational studies","volume":"9","author":"Dancyger","year":"2018","journal-title":"Invest Clin Dent"},{"issue":"5","key":"10.1016\/j.nano.2024.102779_bb0015","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00784-019-02895-z","article-title":"Treatment of actinic cheilitis: a systematic review","volume":"23","author":"Salgueiro","year":"2019","journal-title":"Clin Oral Investig"},{"issue":"4","key":"10.1016\/j.nano.2024.102779_bb0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mjd.2002.126266","article-title":"Topical 5% imiquimod for the therapy of actinic cheilitis","volume":"47","author":"Smith","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.nano.2024.102779_bb0025","first-page":"467","article-title":"Beyond a decade of 5% imiquimod topical therapy","volume":"8","author":"Gaspari","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.nano.2024.102779_bb0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaad.2007.05.022","article-title":"A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma","volume":"57","author":"Eigentler","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.nano.2024.102779_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2007.01.047","article-title":"Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head","volume":"57","author":"Jorizzo","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.nano.2024.102779_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bjoms.2009.08.024","article-title":"Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: clinical and histological outcomes in 5 patients","volume":"48","author":"McDonald","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.nano.2024.102779_bb0045","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2133.2011.10478.x","article-title":"Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study","volume":"165","author":"Sotiriou","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.nano.2024.102779_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmpb.2014.02.017","article-title":"Spatial fuzzy c-means algorithm with adaptive fuzzy exponent selection for robust vermilion border detection in healthy and diseased lower lips","volume":"114","author":"Spyridonos","year":"2014","journal-title":"Comput Methods Prog Biomed"},{"issue":"2","key":"10.1016\/j.nano.2024.102779_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/ced.13763","article-title":"Ingenol mebutate versus imiquimod versus diclofenac for actinic cheilitis: a 6-month follow-up clinical study","volume":"44","author":"Husein-ElAhmed","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.nano.2024.102779_bb0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejpb.2017.01.021","article-title":"The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: increasing penetration and adhesion of imiquimod in vaginal tissue","volume":"114","author":"Frank","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2024.102779_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpb.2019.01.001","article-title":"Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line","volume":"136","author":"Frank","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2024.102779_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejps.2015.08.016","article-title":"Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma","volume":"79","author":"Venturini","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.nano.2024.102779_bb0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijsu.2011.09.004","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"9","author":"Schulz","year":"2011","journal-title":"Int J Surg"},{"key":"10.1016\/j.nano.2024.102779_bb0080","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/bdjopen.2017.16","article-title":"Actinic cheilitis: proposition and reproducibility of a clinical criterion","volume":"3","author":"Poitevin","year":"2017","journal-title":"BDJ Open"},{"issue":"11","key":"10.1016\/j.nano.2024.102779_bb0085","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2200::AID-CNCR19>3.0.CO;2-#","article-title":"Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity","volume":"79","author":"Xie","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.nano.2024.102779_bb0090","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0928-0987(00)00166-4","article-title":"Drug targeting","author":"Torchilin","year":"2000","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.nano.2024.102779_bb0095","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1166\/jbn.2014.1752","article-title":"Combined effect of polymeric nanocapsules and chitosan hydrogel on the increase of capsaicinoids adhesion to the skin surface","volume":"10","author":"Contri","year":"2014","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.nano.2024.102779_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/117739280700200002","article-title":"Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications","volume":"2","author":"Guterres","year":"2007","journal-title":"Drug Target Insights"},{"issue":"1","key":"10.1016\/j.nano.2024.102779_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2013.04.035","article-title":"Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?","volume":"50","author":"Vani\u0107","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10.1016\/j.nano.2024.102779_bb0110","first-page":"3151","article-title":"Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery","volume":"28","author":"Frank","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2024.102779_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejps.2013.11.008","article-title":"Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride","volume":"52","author":"Caon","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2024.102779_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111681","article-title":"Innovative hydrogel containing polymeric nanocapsules loaded with phloretin: enhanced skin penetration and adhesion","volume":"120","author":"Casarini","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"10.1016\/j.nano.2024.102779_bb0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.22456\/2527-2616.125229","article-title":"Lipid core nanocapsules-loaded tacrolimus: development and evaluation of quality parameters","volume":"6","author":"Gomes","year":"2022","journal-title":"Drug Analytical Res"},{"issue":"5","key":"10.1016\/j.nano.2024.102779_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ijcp.12142","article-title":"When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"67","author":"Citrome","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"7","key":"10.1016\/j.nano.2024.102779_bb0135","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/odi.13837","article-title":"Sun protection as a protective factor for actinic cheilitis: cross-sectional population-based study","volume":"28","author":"Lucena","year":"2022","journal-title":"Oral Dis"},{"issue":"4","key":"10.1016\/j.nano.2024.102779_bb0140","first-page":"231","article-title":"Proliferative activity in clinically healthy oral mucosa exposed to tobacco smoking and alcohol: a longitudinal study using the agNOR staining technique","volume":"29","author":"Gedoz","year":"2007","journal-title":"Anal Quant Cytol Histol"},{"issue":"3","key":"10.1016\/j.nano.2024.102779_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmjebm-2020-111573","article-title":"Patient-reported outcome measures (PROMs) as proof of treatment efficacy","volume":"27","author":"Kluzek","year":"2022","journal-title":"BMJ Evid Based Med"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:26:23Z","timestamp":1729754783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963424000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"alternative-id":["S1549963424000480"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2024.102779","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a 0.05\u00a0% nanoencapsulated imiquimod hydrogel for the treatment of actinic cheilitis: Drug release analysis and clinical study","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2024.102779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102779"}}